Cathay Biotech Inc. (SHSE: 688065)
Materials · Chemicals · CN
CN¥36.63
-4.76% today · -22.6% 1Y
Cathay Biotech Inc. (SHSE: 688065) operates in the Chemicals industry within the Materials sector. The company is valued at $3.95B and employs 1,844 people.
Over the last twelve months the share price has lost 22.6%, trading between 35.44 and 64.50.
Tweenvest scores Cathay Biotech Inc. across four factors: quality 77/100, value 69/100, growth 55/100, dividend 46/100. Its strongest factor is quality.
688065 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.95B
- Revenue (TTM)
- $518.85M
- P/E
- 41.85
- EPS
- 0.88
- Dividend yield
- 1.23%
- Beta (5Y)
- 0.47
- 52-week high
- CN¥64.50
- 52-week low
- CN¥35.44
- Avg volume (3M)
- —
- Shares outstanding
- 720.66M
- Employees
- 1,844
- Next earnings
- —
About Cathay Biotech Inc.
Cathay Biotech Inc. specializes in biochemical products, producing and marketing bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company's corporate base is located in Shanghai, China.
- ISIN
- CNE100004447
- Founded
- 2000
- Listed since
- Aug 12, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Clariant AGSWX: CLN | $4.00B | CHF10.03 | -2.15% |
| Air Water Inc.TSE: 4088 | $3.99B | ¥2,745.00 | -3.24% |
| Jinan Shengquan Group Share Holding Co., Ltd.SHSE: 605589 | $3.95B | CN¥31.30 | -7.97% |
| Zhejiang Sanmei Chemical Industry Co.,Ltd.SHSE: 603379 | $3.95B | CN¥43.51 | -9.95% |
| Xinfengming Group Co., Ltd.SHSE: 603225 | $3.92B | CN¥15.88 | -6.59% |
| Johnson Matthey PlcLSE: JMAT | $3.87B | £24.34 | +0.75% |
| Cabot CorporationNYSE: CBT | $3.81B | $73.79 | -0.73% |
| Avient CorporationNYSE: AVNT | $3.76B | $41.03 | +1.11% |
Figures last refreshed Oct 18, 2026.